Biotech / Medical
Sepracor-Looks very promising
An SI Board Since August 1996
Posts SubjectMarks Bans Symbol
10280 116 0 SEPR
Emcee:  rkrw Type:  Unmoderated
I own quite a bit of this company, so naturally I view it as a company to own. I was kind of surprised that it had not been mentioned before. I would like to know if anyone has an interest in the stock, or perhaps knows something I do not. Thank You.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
10280I hadn't posted the actual link, but should have. This is it: phx.corporatRocky9-9/27/2009
10279Thanks for posting the link to the 14D-9. Very interesting read, indeed. ShoulBiotech Jim-9/26/2009
10278Read the Sch 14D-9 last night. Very interesting story about the history of mergRocky9-9/25/2009
102777:27 AM ET Sepracor Raised To Neutral From Sell By Goldman Sachs Way to be on tsjemmeri29/4/2009
10276Thanks, Ken. That's the press release I mentioned. That call was over 9 hoJohn Metcalf-9/3/2009
10275Quote: "Conference Call Information DSP will host an investors meeting in kenhott19/3/2009
10274Dainippon and Sepracor had a joint conference call this morning at 6 EDT. Did aJohn Metcalf-9/3/2009
10273Sepracor Rises on Reported Sale to Dainippon for $2.7 Billion By Tom Randall sim1-9/2/2009
10272UPDATE 1-Dainippon Sumitomo to bid for Sepracor - Nikkei Wed Sep 2, 2009 1:53pm sim1-9/2/2009
10271Sepracor slides on trial failure and Lunesta halt Sepracor says FDA stopped 2 Lutnsaf-7/2/2009
10270Data Demonstrates Long-Term Reduction In Seizure Frequency With Novel Once DailyIcebrg-6/29/2009
10269Perrigo Confirms That its Partner Synthon Has Filed for Generic Version of Xyzalrkrw-6/24/2009
10268>>if so, 60 days are about up.>> MARLBOROUGH, Mass.--(BUSINESS WIREIcebrg-6/1/2009
10267Why is SEPR trading at this valuation......short interest in latest period droppArthur Radley-5/31/2009
10266>>Sepracor Announces Final Settlement of XOPENEX Inhalation Solution Patentuck-3/10/2009
10265I would agree that the market expectations were not significant for this indicatBiotech Jim-3/6/2009
10264>>Sepracor Reports Preliminary Phase II Study Results for SEP-225441 for ttuck-3/5/2009
10263I had the same thought (sale). But it is also reasonable that they are working John Metcalf-2/17/2009
10262Ah ok. Didn't know the notes had a put option! Now it makes sense. Wonder ifrkrw-2/17/2009
10261"Anyone with any guesses why they would be buying these back? " The 2John Metcalf12/17/2009
10260OK. So half life is a bit shorter. When all is said and done, i don't think rkrw-2/17/2009
10259Terrible taste but lower next-day hangover effects for the isomer...idos-2/17/2009
10258By the time a trial ended it may well end up in 2012 anyway. Plus appeals. How mrkrw-2/17/2009
10257Exactly when it was expected as W-H exclusivity expired mid Dec. Patents are runidos12/17/2009
10256Sepracor's Lunesta targeted by genericsBoston Business Journal - by Craig M.rkrw-2/16/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
Copyright © 1995-2018 Knight Sac Media. All rights reserved.Stock quotes are delayed at least 15 minutes - See Terms of Use.